AMYRA Biotech AG is a leader in the development of innovative solutions to support and enhance the digestive capabilities of enzymes lining the small intestine. AMYRA’s Brush Border Enzyme Supplementation Technology (BBEST) pipeline addresses general health and nutrition, food sensitivities, and gastrointestinal diseases. The lead product in AMYRA’s BBEST pipeline, AMYNOPEP01, is the first and only synergistic combination of exopeptidases, enzymes specifically designed to completely digest protein fragments into easily absorbed amino acids.
AMYRA is based in Basel, Switzerland.
Company Details
Amyra Biotech Ag Questions
Amyra Biotech Ag's helpline number is +41 61 515 07 70
Amyra Biotech Ag's website is amyra.com
Amyra Biotech Ag's LinkedIn profile is https://ch.linkedin.com/company/amyra-biotech-ag
Amyra Biotech Ag has
9 employees.
View email and phone details for 9
employees at Amyra Biotech Ag.
Amyra Biotech Ag's industry is
Biotechnology Research
Amyra Biotech Ag's top competitors are
Ymmunobio,
Anaveon Ag,
Novaremed Ag,
Altamira Therapeutics,
Cellestia Biotech,
Stratpharma,
Vaximm Ag,
Canvirex,
Esocap Ag,
Allegria Therapeutics.
Amyra Biotech Ag's categories are Biotechnology Research
Amyra Biotech Ag's founding year is 2013
